Holly Kramer1, Orlando M Gutiérrez2, Suzanne E Judd3, Paul Muntner4, David G Warnock5, Rikki M Tanner4, Bhupesh Panwar5, David A Shoham6, William McClellan7. 1. Department of Public Health Sciences, Division of Nephrology and Hypertension, Loyola University Chicago, Maywood, IL; Department of Medicine, Division of Nephrology and Hypertension, Loyola University Chicago, Maywood, IL. Electronic address: hkramer@luc.edu. 2. Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL. 3. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL. 4. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL. 5. Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. 6. Department of Public Health Sciences, Division of Nephrology and Hypertension, Loyola University Chicago, Maywood, IL. 7. Department of Medicine, Emory University, Atlanta, GA; Department of Epidemiology, Emory University, Atlanta, GA.
Abstract
BACKGROUND: The association between waist circumference and end-stage renal disease (ESRD) remains poorly explored. STUDY DESIGN: Longitudinal population-based cohort. SETTING & PARTICIPANTS: Participants in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study (n=30,239) with information for body mass index (BMI), waist circumference, spot urine albumin-creatinine ratio (ACR), and estimated glomerular filtration rate (eGFR; n=26,960). PREDICTOR: Elevated waist circumference or BMI. OUTCOMES & MEASUREMENTS: Incident cases of ESRD were identified through linkage of REGARDS participants with the US Renal Data System. RESULTS: Mean baseline age was 64.8 years, 45.8% were men, and 40.3% were black. Overall, 297 (1.1%) individuals developed ESRD during a median of 6.3 years. After adjustment for all covariates including waist circumference, no significant association was noted between BMI categories and ESRD incidence compared to BMI of 18.5 to 24.9 kg/m2 (referent). Higher waist circumference categories showed significantly increased hazard rates of ESRD, with waist circumference ≥ 108 cm in women and ≥122 cm in men (highest category) showing a 3.97-fold higher hazard rate (95% CI, 2.10-6.86) for ESRD compared to waist circumference < 80 cm in women and <94 cm in men (referent) after adjusting for demographic factors and BMI. However, no significant association was noted between any waist circumference category and ESRD incidence after adjustment for obesity-associated comorbid conditions and baseline ACR and eGFR. LIMITATIONS: Short follow-up period (6.3 years) to assess ESRD risk among adults with eGFRs>60 mL/min/1.73 m2. CONCLUSIONS: In this cohort of older adults, obesity as measured by waist circumference is associated with higher ESRD risk even with adjustment for BMI, whereas obesity as measured by BMI is not associated with higher ESRD risk after adjustment for waist circumference. However, no significant association is noted between increased waist circumference and ESRD risk after adjustment for obesity-related comorbid conditions, eGFR, and ACR.
BACKGROUND: The association between waist circumference and end-stage renal disease (ESRD) remains poorly explored. STUDY DESIGN: Longitudinal population-based cohort. SETTING & PARTICIPANTS: Participants in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study (n=30,239) with information for body mass index (BMI), waist circumference, spot urine albumin-creatinine ratio (ACR), and estimated glomerular filtration rate (eGFR; n=26,960). PREDICTOR: Elevated waist circumference or BMI. OUTCOMES & MEASUREMENTS: Incident cases of ESRD were identified through linkage of REGARDS participants with the US Renal Data System. RESULTS: Mean baseline age was 64.8 years, 45.8% were men, and 40.3% were black. Overall, 297 (1.1%) individuals developed ESRD during a median of 6.3 years. After adjustment for all covariates including waist circumference, no significant association was noted between BMI categories and ESRD incidence compared to BMI of 18.5 to 24.9 kg/m2 (referent). Higher waist circumference categories showed significantly increased hazard rates of ESRD, with waist circumference ≥ 108 cm in women and ≥122 cm in men (highest category) showing a 3.97-fold higher hazard rate (95% CI, 2.10-6.86) for ESRD compared to waist circumference < 80 cm in women and <94 cm in men (referent) after adjusting for demographic factors and BMI. However, no significant association was noted between any waist circumference category and ESRD incidence after adjustment for obesity-associated comorbid conditions and baseline ACR and eGFR. LIMITATIONS: Short follow-up period (6.3 years) to assess ESRD risk among adults with eGFRs>60 mL/min/1.73 m2. CONCLUSIONS: In this cohort of older adults, obesity as measured by waist circumference is associated with higher ESRD risk even with adjustment for BMI, whereas obesity as measured by BMI is not associated with higher ESRD risk after adjustment for waist circumference. However, no significant association is noted between increased waist circumference and ESRD risk after adjustment for obesity-related comorbid conditions, eGFR, and ACR.
Keywords:
Adiposity; US Renal Data System (USRDS); body mass index (BMI); chronic kidney disease (CKD); chronic renal failure; dialysis; end-stage renal disease (ESRD); obesity; renal failure; waist circumference
Authors: Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox Journal: Obesity (Silver Spring) Date: 2010-12-23 Impact factor: 5.002
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Holly Kramer; David Shoham; Leslie A McClure; Ramon Durazo-Arvizu; George Howard; Suzanne Judd; Paul Muntner; Monika Safford; David G Warnock; William McClellan Journal: Am J Kidney Dis Date: 2011-05-20 Impact factor: 8.860
Authors: Jing Chen; Paul Muntner; L Lee Hamm; Vivian Fonseca; Vecihi Batuman; Paul K Whelton; Jiang He Journal: J Am Soc Nephrol Date: 2003-02 Impact factor: 10.121
Authors: Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy Journal: JAMA Date: 2004-02-18 Impact factor: 56.272
Authors: Essam F Elsayed; Mark J Sarnak; Hocine Tighiouart; John L Griffith; Tobias Kurth; Deeb N Salem; Andrew S Levey; Daniel E Weiner Journal: Am J Kidney Dis Date: 2008-05-29 Impact factor: 8.860
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers Journal: J Am Soc Nephrol Date: 2016-05-13 Impact factor: 10.121